All Stories

  1. Network analyses identify liver‐specific targets for treating liver diseases
  2. AUP1 (Ancient Ubiquitous Protein 1)
  3. Personal model‐assisted identification of NAD + and glutathione metabolism as intervention target in NAFLD
  4. Predicting growth of the healthy infant using a genome scale metabolic model
  5. Editorial: The Impact of Systems Medicine on Human Health and Disease
  6. Adaptive Evolution of Phosphorus Metabolism in Prochlorococcus
  7. Integrated Network Analysis Reveals an Association between Plasma Mannose Levels and Insulin Resistance
  8. Liver: Phenotypic and genetic variance: a systems approach to the liver
  9. Dysregulated signaling hubs of liver lipid metabolism reveal hepatocellular carcinoma pathogenesis
  10. Investigating the Combinatory Effects of Biological Networks on Gene Co-expression
  11. Proteome- and Transcriptome-Driven Reconstruction of the Human Myocyte Metabolic Network and Its Use for Identification of Markers for Diabetes
  12. Personalized Cardiovascular Disease Prediction and Treatment—A Review of Existing Strategies and Novel Systems Medicine Tools
  13. Confounding Effects of Metformin on the Human Gut Microbiome in Type 2 Diabetes
  14. Systems biology analysis of hepatitis C virus infection reveals the role of copy number increases in regions of chromosome 1q in hepatocellular carcinoma metabolism
  15. Cancer Metabolism: A Modeling Perspective
  16. Stratification of Hepatocellular Carcinoma Patients Based on Acetate Utilization
  17. Kinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in Humans
  18. The gut microbiota modulates host amino acid and glutathione metabolism in mice
  19. Extensive weight loss reveals distinct gene expression changes in human subcutaneous and visceral adipose tissue
  20. New paradigms for metabolic modeling of human cells
  21. The human cardiac and skeletal muscle proteomes defined by transcriptomics and antibody-based profiling
  22. Logical transformation of genome-scale metabolic models for gene level applications and analysis
  23. Identifying anti-growth factors for human cancer cell lines through genome-scale metabolic modeling
  24. Modelling the Effect of SPION Size in a Stent Assisted Magnetic Drug Targeting System with Interparticle Interactions
  25. Defining the Human Adipose Tissue Proteome To Reveal Metabolic Alterations in Obesity
  26. Defining the human gallbladder proteome by transcriptomics and affinity proteomics
  27. The use of Genome-scale metabolic models for drug target and biomarker identification
  28. Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease
  29. Understanding the interactions between bacteria in the human gut through metabolic modeling
  30. Genome-scale modeling of human metabolism - a systems biology approach
  31. Reconstruction of Genome-Scale Active Metabolic Networks for 69 Human Cell Types and 16 Cancer Types Using INIT
  32. Systems medicine and metabolic modelling
  33. Inclusion of interactions in mathematical modelling of implant assisted magnetic drug targeting
  34. Development of artificial neuronal networks for molecular communication
  35. Artificial backbone neuronal network for nano scale sensors
  36. Theoretical modelling of physiologically stretched vessel in magnetisable stent assisted magnetic drug targetingapplication
  37. Many particle magnetic dipole–dipole and hydrodynamic interactions in magnetizable stent assisted magnetic drug targeting
  38. Inclusion of magnetic dipole–dipole and hydrodynamic interactions in implant-assisted magnetic drug targeting
  39. Calculation of nanoparticle capture efficiency in magnetic drug targeting